Smoking Cessation and Nicotine De-addiction Products Market Expected to Reach USD 16.02Billion Globally in 2019: Transparency Market Research
Poster: SySAdmin
Posted on March 25, 2014 at 9:56:01 AM
Smoking Cessation and Nicotine De-addiction Products Market Expected to Reach USD 16.02Billion Globally in 2019: Transparency Market Research
ALBANY, New York, March 25, 2014 /PRNewswire/ --
According to a new market report published by Transparency Market Research "Smoking
Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges,
Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes)- Global
Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global
smoking cessation and nicotine de-addiction productsmarket was valued at USD 5.1 billion
in 2012 and is expected to grow at a CAGR of 18.7% from 2013 to 2019, to reach an
estimated value of USD 16.02billion in 2019.
Smoking cessation is a process of discontinuing smoking achieved by the use of
medication. It may also be coupled with assistance of healthcare professionals,
counselling and psychotherapy. The demand for smoking cessation products is high and is
continuously rising as it caters to the needs of people addicted to nicotine and rising
healthcare awareness amongst the smokers. The global smoking cessation and nicotine
de-addiction products market is segmented on the basis of product types available in the
market. These include nicotine replacement therapy (NRT) products, drug therapy and
e-cigarettes. This market is sustained by large number of people wanting to quit smoking.
Browse Global Smoking Cessation and Nicotine De-addiction Products Market Report with
Full TOC at
http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html
NRT products for smoking cessation include nicotine containing gums, patches,
lozenges, sublingual tablets, inhalers and mouth sprays. The market for NRT products is
dominated by the revenue of nicotine gums, patches and lozenges. Nicotine gums are one of
the most widely used NRT products, and the market for these was valued at USD 995.5
million in 2012. The nicotine patches and lozenges market is driven by its ease of use and
non-prescription sale. Nicotine sprays and inhalers on the other hand are less preferred
due to their high cost and less popularity. However, increased promotional activities and
effective distribution is expected to boost their market growth in the near future. The
major players in the NRT products market include Johnson and Johnson, GSK, Cipla and
Novartis.
Smoking cessation drug therapy market is expected to witness a decline in revenue
across the globe, by the end of the forecast period due to patent expiration of the key
revenue generating drugs Zyban (bupropion) in 2013 and Chantix/Champix (varenicline) in
2018 (which will impede market growth toa lower extent). The loss of patent and marketing
exclusivity will lead to a drastic reduction in revenue and in turn provide an opportunity
to generic manufacturers to launch their own versions of these brands. The leading players
in the drug therapy market are GSK and Pfizer.
The e-cigarettes segment is expected to witness the fastest growth, and thus, will
boost growth of the global smoking cessation and nicotine de-addiction products market
during the forecast period. E-cigarettes have proved to be a better alternative to
cigarettes whose smoke contains various harmful gases and cause dreadful diseases such as
cancer. With the exceptional growth and popularity among the younger population, the
market has posed a challenge to other smoking cessation products as well as to the tobacco
cigarette business. The global e-cigarettes market was worth USD 1,662.5 million in 2012.
Lorillard, NJOY and VMR products LLC are some of the major players in the e-cigarettes
market.
Geographically, North America dominates the global smoking cessation and nicotine
de-addiction products market. The North American market for smoking cessation products was
valued at USD 1,958.8 million in the year 2012. An increase in cigarette costs is expected
to reduce smoking rates significantly, especially in adolescents. According to the CDC, a
10% rise in cigarettes cost can cut around 4% of young adults craving cigarette
consumption. The European market held the second largest share worldwide, in 2012. WHO
reports that European countries have widely adopted bans on tobacco advertising, promotion
on national/international television and radio, billboards and outdoor advertising, local
magazines and newspapers. However, some countries in Europe still lack in implementing
measures of the WHO Framework Convention on Tobacco Control (FCTC).
Related & Recently Published Reports by Transparency Market Research
- Drugs of Abuse Testing Market:
http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html
- Orthopedic Devices Market:
http://www.transparencymarketresearch.com/orthopedic-devices-market.html
- Endocrine Testing Market:
http://www.transparencymarketresearch.com/endocrine-testing-market.html
- Life Sciences BPO Market:
http://www.transparencymarketresearch.com/life-sciences-bpo-market.html
- Building and Construction Plastics Market:
http://www.transparencymarketresearch.com/building-construction-plastics-market.html
- Blood Flow Measurement Devices Market:
http://www.transparencymarketresearch.com/blood-flow-measurement-devices.html
- Organ Preservation Solutions Market:
http://www.transparencymarketresearch.com/organ-preservation-solutions.html
Raising taxes to increase the cost of cigarettes can reduce tobacco use, cut smoking
rates, and ultimately save lives. Smoking prevalence has been varying across the globe
with many developing countries witnessing rapid increase in the prevalence rate, which
will create huge health problems for the future if left unchecked. Demand for lifestyle
drugs in emerging countries is witnessing rapid growth due to factors including growing
health awareness, increase in population, and development of public healthcare systems,
among others. This is driving people towards quitting smoking by adopting smoking
cessation products. A study in the Eastern Mediterranean Health Journal, published in
2012, reported that nicotine containing medications are not available in one third of the
developing countries, which include the Middle East and Africa. Moreover, accessibility of
non-nicotine containing medications such as bupropion and varenicline is also extremely
low. Increased attention and resources are needed to address lack of smoking cessation
services as well as access to nicotine containing medications in these regions.
The global smoking cessation and nicotine de-addiction products market is segmented as
follows
Smoking Cessation and Nicotine De-Addiction Products Market, by Product Type
- Nicotine Replacement Therapy Products
- Nicotine Gums
- Nicotine Transdermal Patches
- Nicotine Lozenges
- Nicotine Sprays
- Nicotine Inhalers
- Nicotine Sublingual Tablets
- Drug Therapy
- Zyban (bupropion)
- Chantix/Champix (varenicline)
- E-cigarettes
Browse Smoking Cessation and Nicotine De-addiction Products Market Report at
http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html
Smoking Cessation and Nicotine De-Addiction Products Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Browse all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us
Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze
information.
Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business
reports.
Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com
Blog: http://transparencymarketresearch.areavoices.com
http://www.transparencymarketresearch.com/
ALBANY, New York, March 25, 2014 /PRNewswire/ --
According to a new market report published by Transparency Market Research "Smoking
Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges,
Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes)- Global
Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global
smoking cessation and nicotine de-addiction productsmarket was valued at USD 5.1 billion
in 2012 and is expected to grow at a CAGR of 18.7% from 2013 to 2019, to reach an
estimated value of USD 16.02billion in 2019.
Smoking cessation is a process of discontinuing smoking achieved by the use of
medication. It may also be coupled with assistance of healthcare professionals,
counselling and psychotherapy. The demand for smoking cessation products is high and is
continuously rising as it caters to the needs of people addicted to nicotine and rising
healthcare awareness amongst the smokers. The global smoking cessation and nicotine
de-addiction products market is segmented on the basis of product types available in the
market. These include nicotine replacement therapy (NRT) products, drug therapy and
e-cigarettes. This market is sustained by large number of people wanting to quit smoking.
Browse Global Smoking Cessation and Nicotine De-addiction Products Market Report with
Full TOC at
http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html
NRT products for smoking cessation include nicotine containing gums, patches,
lozenges, sublingual tablets, inhalers and mouth sprays. The market for NRT products is
dominated by the revenue of nicotine gums, patches and lozenges. Nicotine gums are one of
the most widely used NRT products, and the market for these was valued at USD 995.5
million in 2012. The nicotine patches and lozenges market is driven by its ease of use and
non-prescription sale. Nicotine sprays and inhalers on the other hand are less preferred
due to their high cost and less popularity. However, increased promotional activities and
effective distribution is expected to boost their market growth in the near future. The
major players in the NRT products market include Johnson and Johnson, GSK, Cipla and
Novartis.
Smoking cessation drug therapy market is expected to witness a decline in revenue
across the globe, by the end of the forecast period due to patent expiration of the key
revenue generating drugs Zyban (bupropion) in 2013 and Chantix/Champix (varenicline) in
2018 (which will impede market growth toa lower extent). The loss of patent and marketing
exclusivity will lead to a drastic reduction in revenue and in turn provide an opportunity
to generic manufacturers to launch their own versions of these brands. The leading players
in the drug therapy market are GSK and Pfizer.
The e-cigarettes segment is expected to witness the fastest growth, and thus, will
boost growth of the global smoking cessation and nicotine de-addiction products market
during the forecast period. E-cigarettes have proved to be a better alternative to
cigarettes whose smoke contains various harmful gases and cause dreadful diseases such as
cancer. With the exceptional growth and popularity among the younger population, the
market has posed a challenge to other smoking cessation products as well as to the tobacco
cigarette business. The global e-cigarettes market was worth USD 1,662.5 million in 2012.
Lorillard, NJOY and VMR products LLC are some of the major players in the e-cigarettes
market.
Geographically, North America dominates the global smoking cessation and nicotine
de-addiction products market. The North American market for smoking cessation products was
valued at USD 1,958.8 million in the year 2012. An increase in cigarette costs is expected
to reduce smoking rates significantly, especially in adolescents. According to the CDC, a
10% rise in cigarettes cost can cut around 4% of young adults craving cigarette
consumption. The European market held the second largest share worldwide, in 2012. WHO
reports that European countries have widely adopted bans on tobacco advertising, promotion
on national/international television and radio, billboards and outdoor advertising, local
magazines and newspapers. However, some countries in Europe still lack in implementing
measures of the WHO Framework Convention on Tobacco Control (FCTC).
Related & Recently Published Reports by Transparency Market Research
- Drugs of Abuse Testing Market:
http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html
- Orthopedic Devices Market:
http://www.transparencymarketresearch.com/orthopedic-devices-market.html
- Endocrine Testing Market:
http://www.transparencymarketresearch.com/endocrine-testing-market.html
- Life Sciences BPO Market:
http://www.transparencymarketresearch.com/life-sciences-bpo-market.html
- Building and Construction Plastics Market:
http://www.transparencymarketresearch.com/building-construction-plastics-market.html
- Blood Flow Measurement Devices Market:
http://www.transparencymarketresearch.com/blood-flow-measurement-devices.html
- Organ Preservation Solutions Market:
http://www.transparencymarketresearch.com/organ-preservation-solutions.html
Raising taxes to increase the cost of cigarettes can reduce tobacco use, cut smoking
rates, and ultimately save lives. Smoking prevalence has been varying across the globe
with many developing countries witnessing rapid increase in the prevalence rate, which
will create huge health problems for the future if left unchecked. Demand for lifestyle
drugs in emerging countries is witnessing rapid growth due to factors including growing
health awareness, increase in population, and development of public healthcare systems,
among others. This is driving people towards quitting smoking by adopting smoking
cessation products. A study in the Eastern Mediterranean Health Journal, published in
2012, reported that nicotine containing medications are not available in one third of the
developing countries, which include the Middle East and Africa. Moreover, accessibility of
non-nicotine containing medications such as bupropion and varenicline is also extremely
low. Increased attention and resources are needed to address lack of smoking cessation
services as well as access to nicotine containing medications in these regions.
The global smoking cessation and nicotine de-addiction products market is segmented as
follows
Smoking Cessation and Nicotine De-Addiction Products Market, by Product Type
- Nicotine Replacement Therapy Products
- Nicotine Gums
- Nicotine Transdermal Patches
- Nicotine Lozenges
- Nicotine Sprays
- Nicotine Inhalers
- Nicotine Sublingual Tablets
- Drug Therapy
- Zyban (bupropion)
- Chantix/Champix (varenicline)
- E-cigarettes
Browse Smoking Cessation and Nicotine De-addiction Products Market Report at
http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html
Smoking Cessation and Nicotine De-Addiction Products Market, by Geography
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Browse all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us
Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze
information.
Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business
reports.
Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com
Blog: http://transparencymarketresearch.areavoices.com
http://www.transparencymarketresearch.com/